ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,371Medicare Part D Prescriptions Filled, Including Refills

Rank: 35 out of 1107

$1.21M Total Retail Price of All Prescriptions

Rank: 55 out of 1107

1,067 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 1,067 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

20% of this provider’s 1,067 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 18,457 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 989 657 S3 1 1
SIMVASTATIN 966 802 2 5
LISINOPRIL 932 732 3 2
LEVOTHYROXINE SODIUM 830 613 4 3
OMEPRAZOLE 828 646 5 4
PRAVASTATIN SODIUM 534 423 6 12
METFORMIN HCL 485 386 7 8
FUROSEMIDE 464 406 8 7
ATENOLOL 406 330 9 19
WARFARIN SODIUM 380 333 10 15
NEXIUM 361 186 11 18
ATORVASTATIN CALCIUM 358 264 12 13
METOPROLOL TARTRATE 337 287 13 10
AMLODIPINE BESYLATE 303 254 14 6
CITALOPRAM HBR 284 224 15 17
POTASSIUM CHLORIDE 269 176 16 14
GABAPENTIN 265 170 17 9
LOVASTATIN 264 194 18 55
CLOPIDOGREL 259 228 19 28
HYDROCHLOROTHIAZIDE 258 228 20 11
ALENDRONATE SODIUM 255 235 21 41
ZOLPIDEM TARTRATE 251 161 22 22
AZITHROMYCIN 250 170 23 35
GLIPIZIDE 230 190 24 64
LISINOPRIL-HYDROCHLOROTHIAZIDE 225 174 25 24
CIPROFLOXACIN HCL 225 172 25 59
MELOXICAM 223 184 27 25
AMOXICILLIN 217 166 28 90
LOSARTAN POTASSIUM 214 179 29 29
TRAMADOL HCL 213 144 30 26
PANTOPRAZOLE SODIUM 203 143 31 30
CYCLOBENZAPRINE HCL 202 95 R 32 56
SERTRALINE HCL 198 86 33 20
TRIAMTERENE-HCTZ 191 172 34 62
DIOVAN 176 174 35 51
ALPRAZOLAM 168 101 36 87
CRESTOR 167 160 37 23
PAROXETINE HCL 165 105 38 45
PLAVIX 160 150 39 39
CARVEDILOL 158 136 40 27
DIGOXIN 154 115 41 52
GLIMEPIRIDE 154 122 41 43
METOPROLOL SUCCINATE 153 129 43 16
ALLOPURINOL 148 142 44 36
DONEPEZIL HCL 145 145 45 32
AMITRIPTYLINE HCL 136 109 R 46 48
ZETIA 129 104 47 76
VERAPAMIL ER 128 118 48 113
TRAZODONE HCL 126 57 49 33
ESTRADIOL 125 96 R 50 151
JANUVIA 123 90 51 60
SYNTHROID 119 113 52 70
ISOSORBIDE MONONITRATE ER 118 112 53 34
LOSARTAN-HYDROCHLOROTHIAZIDE 116 86 54 66
RANITIDINE HCL 114 68 55 21
AMLODIPINE BESYLATE-BENAZEPRIL 109 106 56 77
TAMSULOSIN HCL 107 74 57 30
LANTUS 103 85 58 49
ESCITALOPRAM OXALATE 101 79 59 82
FENOFIBRATE 99 67 60 67
SPIRONOLACTONE 98 50 61 72
KLOR-CON M20 97 78 62 75
LANSOPRAZOLE 93 86 63 102
NAPROXEN 92 60 64 80
DIOVAN HCT 91 70 65 106
TRIAMCINOLONE ACETONIDE 91 71 65 137
IBUPROFEN 90 38 67 63
FLUTICASONE PROPIONATE 89 67 68 38
OXYBUTYNIN CHLORIDE 86 57 69 171
ACETAMINOPHEN-CODEINE 85 68 S3 70 120
RAMIPRIL 84 67 71 84
PROAIR HFA 83 31 72 37
FINASTERIDE 82 65 73 130
DILTIAZEM ER 81 81 74 139
ETODOLAC 80 61 75 210
METHYLPREDNISOLONE 80 51 75 119
PREMARIN 78 69 R 77 149
CELEBREX 76 48 78 85
SINGULAIR 75 34 79 65
TRIAMTERENE-HYDROCHLOROTHIAZID 74 65 80 185
DICLOFENAC SODIUM 73 45 81 74
INSULIN SYRINGE 73 53 81 78
LIPITOR 72 51 83 109
ATENOLOL-CHLORTHALIDONE 67 56 84 189
PROPRANOLOL HCL 67 42 84 134
TERAZOSIN HCL 67 52 84 173
TRICOR 66 32 87 95
PROMETHAZINE HCL 66 44 R 87 44
DOXAZOSIN MESYLATE 65 65 89 92
NABUMETONE 65 53 89 181
OXYCODONE HCL-ACETAMINOPHEN 65 28 S2 89 93
CILOSTAZOL 63 60 92 194
ADVAIR DISKUS 63 38 92 54
DILTIAZEM 24HR ER 63 59 92 172
JANUMET 62 24 95 197
DILTIAZEM 24HR CD 62 43 95 126
VENLAFAXINE HCL ER 62 46 95 117
ENALAPRIL MALEATE 58 45 98 98
DOXEPIN HCL 55 48 99 180
ROPINIROLE HCL 54 46 100 69
MONTELUKAST SODIUM 54 26 100 118
CLONIDINE HCL 54 34 100 53
OXYBUTYNIN CHLORIDE ER 52 38 103 179
BENAZEPRIL HCL 52 43 103 86
HYDROXYZINE HCL 51 28 R 105 162
TESTOSTERONE CYPIONATE 51 33 S3 105 473
AMPHETAMINE SALT COMBO 50 23 S2 107 300
EVISTA 50 50 107 135
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.